Skip to content

Medtronic MDT Restructuring Charges

Restructuring Charges at other companies

TFX
TeleflexTFX
$16.85M+1,085%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$32M+88.2%
Boston Scientific logo
Boston ScientificBSX
$3M-70.0%

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$103.66B-6.0%
Enterprise value$130.92B-5.0%
P/E21.6×-2.1×
P/S2.9×-0.4×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The official record: Medtronic’s 10-Q, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medtronic's restructuring charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medtronic's restructuring charges?
Medtronic (MDT) reported restructuring charges of $172M in Q4 2025.
How has Medtronic's restructuring charges changed year-over-year?
Medtronic's restructuring charges increased by 273.9% year-over-year, from $46M to $172M.
What does restructuring charges mean?
One-time costs from reorganizing operations, including employee severance, facility closure costs, contract termination fees, and asset relocation expenses.